The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease
Summary Pneumococcal conjugate vaccines (PCVs) are a potentially useful complement to existing treatment strategies in HIV-infected children, for whom pneumococcal infections are common and serious. This Review summarises available data on the burden of pneumococcal disease and the safety and effica...
Gespeichert in:
| Veröffentlicht in: | The Lancet infectious diseases 2008, Vol.8 (1), p.67-80 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 80 |
|---|---|
| container_issue | 1 |
| container_start_page | 67 |
| container_title | The Lancet infectious diseases |
| container_volume | 8 |
| creator | Bliss, Sandra J, Dr O'Brien, Katherine L, MD Janoff, Edward N, Prof Cotton, Mark F, MBChB Musoke, Philippa, MBChB Coovadia, Hoosen, Prof Levine, Orin S, PhD |
| description | Summary Pneumococcal conjugate vaccines (PCVs) are a potentially useful complement to existing treatment strategies in HIV-infected children, for whom pneumococcal infections are common and serious. This Review summarises available data on the burden of pneumococcal disease and the safety and efficacy of PCVs in HIV-infected children. The data demonstrate that children with HIV have significantly increased risk of pneumococcal disease compared with uninfected children; the serotypes included in currently licensed or near-licensure conjugate vaccines include most serotypes that cause invasive pneumococcal disease (IPD) in HIV-infected children and adults; PCVs provide substantial protection against IPD and clinical pneumonia when given to HIV-infected infants; and HIV-infected adults gain an indirect benefit when children in the community are vaccinated. PCV should be considered as an important intervention for improving the lives of HIV-infected children. |
| doi_str_mv | 10.1016/S1473-3099(07)70242-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70157208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309907702426</els_id><sourcerecordid>1666612701</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-d75e433edaf951484bb9efb6ebe98031f4a1cf2ed0ef844c2528302edac3ca6d3</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhSNERUvhJ4AsJBA9BGzHiZMLCFXQVqrEgcLVcsbjrZesvbWTlfrvcTarVuqFk8fWN2-e3xTFG0Y_Mcqaz7-YkFVZ0a77SOWZpFzwsnlWnORnUQpRy-f7ekGOi5cprSllklHxojhmspNCtPSkWN3cIsGdM-gBiQ2RTMn5FYHg19NKj0h2GsB5TGQMZBvDiDCSy6s_pfM2l2gI3LrBRPREr7TzaSRbj9MmQADQAzEuoU74qjiyekj4-nCeFr9_fL85vyyvf15cnX-7LkHIeiyNrFFUFRptu5qJVvR9h7ZvsMeupRWzQjOwHA1F2woBvOZtRfNdQwW6MdVp8WHRzVbvJkyj2rgEOAzaY5iSkpTVktM2g--egOswRZ-9KZ6ZeRjPUL1AEENKEa3aRrfR8V4xquY1qP0a1JyxolLt16Ca3Pf2ID71GzSPXYfcM_D-AOiUU7JRe3Dpkes60TA-u_y6cJgz2zmMKoGbV2VczOkrE9x_rXx5ogCD8y4P_Yv3mB4-zVTiii4iswaVe4Wm-ge1X7o2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201580312</pqid></control><display><type>article</type><title>The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Bliss, Sandra J, Dr ; O'Brien, Katherine L, MD ; Janoff, Edward N, Prof ; Cotton, Mark F, MBChB ; Musoke, Philippa, MBChB ; Coovadia, Hoosen, Prof ; Levine, Orin S, PhD</creator><creatorcontrib>Bliss, Sandra J, Dr ; O'Brien, Katherine L, MD ; Janoff, Edward N, Prof ; Cotton, Mark F, MBChB ; Musoke, Philippa, MBChB ; Coovadia, Hoosen, Prof ; Levine, Orin S, PhD</creatorcontrib><description>Summary Pneumococcal conjugate vaccines (PCVs) are a potentially useful complement to existing treatment strategies in HIV-infected children, for whom pneumococcal infections are common and serious. This Review summarises available data on the burden of pneumococcal disease and the safety and efficacy of PCVs in HIV-infected children. The data demonstrate that children with HIV have significantly increased risk of pneumococcal disease compared with uninfected children; the serotypes included in currently licensed or near-licensure conjugate vaccines include most serotypes that cause invasive pneumococcal disease (IPD) in HIV-infected children and adults; PCVs provide substantial protection against IPD and clinical pneumonia when given to HIV-infected infants; and HIV-infected adults gain an indirect benefit when children in the community are vaccinated. PCV should be considered as an important intervention for improving the lives of HIV-infected children.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(07)70242-6</identifier><identifier>PMID: 17974480</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>AIDS-Related Opportunistic Infections - microbiology ; AIDS-Related Opportunistic Infections - prevention & control ; Antiretroviral Therapy, Highly Active - methods ; Bacterial diseases ; Biological and medical sciences ; Child ; HIV ; HIV Infections - immunology ; HIV Infections - microbiology ; Human bacterial diseases ; Human viral diseases ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infectious Disease ; Infectious diseases ; Medical sciences ; Pneumococcal Infections - prevention & control ; Pneumococcal Infections - virology ; Pneumococcal Vaccines - immunology ; Pneumococcal Vaccines - therapeutic use ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Streptococcus pneumoniae - immunology ; Vaccines ; Vaccines, Conjugate - immunology ; Vaccines, Conjugate - therapeutic use ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>The Lancet infectious diseases, 2008, Vol.8 (1), p.67-80</ispartof><rights>Elsevier Ltd</rights><rights>2008 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jan 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-d75e433edaf951484bb9efb6ebe98031f4a1cf2ed0ef844c2528302edac3ca6d3</citedby><cites>FETCH-LOGICAL-c475t-d75e433edaf951484bb9efb6ebe98031f4a1cf2ed0ef844c2528302edac3ca6d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1473309907702426$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19946128$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17974480$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bliss, Sandra J, Dr</creatorcontrib><creatorcontrib>O'Brien, Katherine L, MD</creatorcontrib><creatorcontrib>Janoff, Edward N, Prof</creatorcontrib><creatorcontrib>Cotton, Mark F, MBChB</creatorcontrib><creatorcontrib>Musoke, Philippa, MBChB</creatorcontrib><creatorcontrib>Coovadia, Hoosen, Prof</creatorcontrib><creatorcontrib>Levine, Orin S, PhD</creatorcontrib><title>The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Summary Pneumococcal conjugate vaccines (PCVs) are a potentially useful complement to existing treatment strategies in HIV-infected children, for whom pneumococcal infections are common and serious. This Review summarises available data on the burden of pneumococcal disease and the safety and efficacy of PCVs in HIV-infected children. The data demonstrate that children with HIV have significantly increased risk of pneumococcal disease compared with uninfected children; the serotypes included in currently licensed or near-licensure conjugate vaccines include most serotypes that cause invasive pneumococcal disease (IPD) in HIV-infected children and adults; PCVs provide substantial protection against IPD and clinical pneumonia when given to HIV-infected infants; and HIV-infected adults gain an indirect benefit when children in the community are vaccinated. PCV should be considered as an important intervention for improving the lives of HIV-infected children.</description><subject>AIDS-Related Opportunistic Infections - microbiology</subject><subject>AIDS-Related Opportunistic Infections - prevention & control</subject><subject>Antiretroviral Therapy, Highly Active - methods</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>HIV</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - microbiology</subject><subject>Human bacterial diseases</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Pneumococcal Infections - prevention & control</subject><subject>Pneumococcal Infections - virology</subject><subject>Pneumococcal Vaccines - immunology</subject><subject>Pneumococcal Vaccines - therapeutic use</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><subject>Streptococcus pneumoniae - immunology</subject><subject>Vaccines</subject><subject>Vaccines, Conjugate - immunology</subject><subject>Vaccines, Conjugate - therapeutic use</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkUFv1DAQhSNERUvhJ4AsJBA9BGzHiZMLCFXQVqrEgcLVcsbjrZesvbWTlfrvcTarVuqFk8fWN2-e3xTFG0Y_Mcqaz7-YkFVZ0a77SOWZpFzwsnlWnORnUQpRy-f7ekGOi5cprSllklHxojhmspNCtPSkWN3cIsGdM-gBiQ2RTMn5FYHg19NKj0h2GsB5TGQMZBvDiDCSy6s_pfM2l2gI3LrBRPREr7TzaSRbj9MmQADQAzEuoU74qjiyekj4-nCeFr9_fL85vyyvf15cnX-7LkHIeiyNrFFUFRptu5qJVvR9h7ZvsMeupRWzQjOwHA1F2woBvOZtRfNdQwW6MdVp8WHRzVbvJkyj2rgEOAzaY5iSkpTVktM2g--egOswRZ-9KZ6ZeRjPUL1AEENKEa3aRrfR8V4xquY1qP0a1JyxolLt16Ca3Pf2ID71GzSPXYfcM_D-AOiUU7JRe3Dpkes60TA-u_y6cJgz2zmMKoGbV2VczOkrE9x_rXx5ogCD8y4P_Yv3mB4-zVTiii4iswaVe4Wm-ge1X7o2</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>Bliss, Sandra J, Dr</creator><creator>O'Brien, Katherine L, MD</creator><creator>Janoff, Edward N, Prof</creator><creator>Cotton, Mark F, MBChB</creator><creator>Musoke, Philippa, MBChB</creator><creator>Coovadia, Hoosen, Prof</creator><creator>Levine, Orin S, PhD</creator><general>Elsevier Ltd</general><general>Lancet Publishing Group</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>2008</creationdate><title>The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease</title><author>Bliss, Sandra J, Dr ; O'Brien, Katherine L, MD ; Janoff, Edward N, Prof ; Cotton, Mark F, MBChB ; Musoke, Philippa, MBChB ; Coovadia, Hoosen, Prof ; Levine, Orin S, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-d75e433edaf951484bb9efb6ebe98031f4a1cf2ed0ef844c2528302edac3ca6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>AIDS-Related Opportunistic Infections - microbiology</topic><topic>AIDS-Related Opportunistic Infections - prevention & control</topic><topic>Antiretroviral Therapy, Highly Active - methods</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>HIV</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - microbiology</topic><topic>Human bacterial diseases</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Pneumococcal Infections - prevention & control</topic><topic>Pneumococcal Infections - virology</topic><topic>Pneumococcal Vaccines - immunology</topic><topic>Pneumococcal Vaccines - therapeutic use</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><topic>Streptococcus pneumoniae - immunology</topic><topic>Vaccines</topic><topic>Vaccines, Conjugate - immunology</topic><topic>Vaccines, Conjugate - therapeutic use</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bliss, Sandra J, Dr</creatorcontrib><creatorcontrib>O'Brien, Katherine L, MD</creatorcontrib><creatorcontrib>Janoff, Edward N, Prof</creatorcontrib><creatorcontrib>Cotton, Mark F, MBChB</creatorcontrib><creatorcontrib>Musoke, Philippa, MBChB</creatorcontrib><creatorcontrib>Coovadia, Hoosen, Prof</creatorcontrib><creatorcontrib>Levine, Orin S, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bliss, Sandra J, Dr</au><au>O'Brien, Katherine L, MD</au><au>Janoff, Edward N, Prof</au><au>Cotton, Mark F, MBChB</au><au>Musoke, Philippa, MBChB</au><au>Coovadia, Hoosen, Prof</au><au>Levine, Orin S, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2008</date><risdate>2008</risdate><volume>8</volume><issue>1</issue><spage>67</spage><epage>80</epage><pages>67-80</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>Summary Pneumococcal conjugate vaccines (PCVs) are a potentially useful complement to existing treatment strategies in HIV-infected children, for whom pneumococcal infections are common and serious. This Review summarises available data on the burden of pneumococcal disease and the safety and efficacy of PCVs in HIV-infected children. The data demonstrate that children with HIV have significantly increased risk of pneumococcal disease compared with uninfected children; the serotypes included in currently licensed or near-licensure conjugate vaccines include most serotypes that cause invasive pneumococcal disease (IPD) in HIV-infected children and adults; PCVs provide substantial protection against IPD and clinical pneumonia when given to HIV-infected infants; and HIV-infected adults gain an indirect benefit when children in the community are vaccinated. PCV should be considered as an important intervention for improving the lives of HIV-infected children.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>17974480</pmid><doi>10.1016/S1473-3099(07)70242-6</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1473-3099 |
| ispartof | The Lancet infectious diseases, 2008, Vol.8 (1), p.67-80 |
| issn | 1473-3099 1474-4457 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70157208 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | AIDS-Related Opportunistic Infections - microbiology AIDS-Related Opportunistic Infections - prevention & control Antiretroviral Therapy, Highly Active - methods Bacterial diseases Biological and medical sciences Child HIV HIV Infections - immunology HIV Infections - microbiology Human bacterial diseases Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious Disease Infectious diseases Medical sciences Pneumococcal Infections - prevention & control Pneumococcal Infections - virology Pneumococcal Vaccines - immunology Pneumococcal Vaccines - therapeutic use Staphylococcal infections, streptococcal infections, pneumococcal infections Streptococcus pneumoniae - immunology Vaccines Vaccines, Conjugate - immunology Vaccines, Conjugate - therapeutic use Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids |
| title | The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A37%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20evidence%20for%20using%20conjugate%20vaccines%20to%20protect%20HIV-infected%20children%20against%20pneumococcal%20disease&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Bliss,%20Sandra%20J,%20Dr&rft.date=2008&rft.volume=8&rft.issue=1&rft.spage=67&rft.epage=80&rft.pages=67-80&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(07)70242-6&rft_dat=%3Cproquest_cross%3E1666612701%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201580312&rft_id=info:pmid/17974480&rft_els_id=S1473309907702426&rfr_iscdi=true |